| NCT04137289 |
A First-in-human Phase Ia/b, Open Label, Multicentre, Dose Escalation Study of BI 905711 in Patients With Advanced Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT04137289 |
Recruiting |
Boehringer Ingelheim |
2023-04-04 |
| NCT03360695 |
Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer |
https://ClinicalTrials.gov/show/NCT03360695 |
Recruiting |
Massachusetts General Hospital |
2022-05-15 |
| NCT03343301 |
A Study of FPA144 Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer |
https://ClinicalTrials.gov/show/NCT03343301 |
Active, not recruiting |
Five Prime Therapeutics, Inc. |
2022-07-01 |
| NCT03337087 |
Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer |
https://ClinicalTrials.gov/show/NCT03337087 |
Recruiting |
Academic and Community Cancer Research United |
2020-11-07 |
| NCT03331406 |
Physical Activity In Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT03331406 |
Completed |
Dana-Farber Cancer Institute |
2019-01-22 |
| NCT03329690 |
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] |
https://ClinicalTrials.gov/show/NCT03329690 |
Active, not recruiting |
Daiichi Sankyo, Inc. |
2020-09-30 |
| NCT03321396 |
Hydrogel Injection to Assist Endoscopic Submucosal Dissection |
https://ClinicalTrials.gov/show/NCT03321396 |
Completed |
National Cheng-Kung University Hospital |
2018-08-20 |
| NCT03309917 |
The Effect of Blood Pressure on Cerebral Blood Flow During Propofol Anesthesia |
https://ClinicalTrials.gov/show/NCT03309917 |
Completed |
Rigshospitalet, Denmark |
2018-04-19 |
| NCT03306693 |
Educational Intervention to Increase the Emotional Competence of Patients With Oesogastric and Bronchopulmonary Cancers |
https://ClinicalTrials.gov/show/NCT03306693 |
Recruiting |
University Hospital, Lille |
2019-10-31 |
| NCT03271255 |
Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) |
https://ClinicalTrials.gov/show/NCT03271255 |
Recruiting |
Shenzhen People’s Hospital |
2022-09-30 |
| NCT03267524 |
Walking for Recovery From Surgery in Improving Quality of Life in Older Adults With Lung or Gastrointestinal Cancer and Their Family Caregivers |
https://ClinicalTrials.gov/show/NCT03267524 |
Active, not recruiting |
City of Hope Medical Center |
2020-11-30 |
| NCT03221335 |
EUS-guided RFA for Solid Abdominal Neoplasms |
https://ClinicalTrials.gov/show/NCT03221335 |
Recruiting |
Chinese University of Hong Kong |
2021-04-30 |
| NCT03190941 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients |
https://ClinicalTrials.gov/show/NCT03190941 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2027-06-29 |
| NCT03117348 |
Gradual Versus Immediate Goal-dose Enteral Nutrition in Abdominal Surgery Patients |
https://ClinicalTrials.gov/show/NCT03117348 |
Completed |
Jinling Hospital, China |
2018-12-24 |
| NCT03115957 |
Early Versus Delayed Parenteral Nutrition in Abdominal Surgical Patients |
https://ClinicalTrials.gov/show/NCT03115957 |
Completed |
Jinling Hospital, China |
2018-12-30 |
| NCT03115398 |
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery |
https://ClinicalTrials.gov/show/NCT03115398 |
Active, not recruiting |
Albert Einstein College of Medicine |
2020-03-03 |
| NCT03086291 |
A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy |
https://ClinicalTrials.gov/show/NCT03086291 |
Recruiting |
Samsung Medical Center |
2020-09-30 |
| NCT03072472 |
BowelScope: Accuracy of Detection Using ENdocuff Optimisation of Mucosal Abnormalities |
https://ClinicalTrials.gov/show/NCT03072472 |
Completed |
South Tyneside and Sunderland NHS Foundation Trust |
2018-02-13 |
| NCT02923934 |
A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers |
https://ClinicalTrials.gov/show/NCT02923934 |
Active, not recruiting |
Olivia Newton-John Cancer Research Institute |
2023-08-31 |
| NCT02897778 |
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT02897778 |
Completed |
Syndax Pharmaceuticals |
2017-03-31 |
| NCT02859064 |
Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres |
https://ClinicalTrials.gov/show/NCT02859064 |
Active, not recruiting |
SCRI Development Innovations, LLC |
2020-04-30 |
| NCT02853474 |
Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy |
https://ClinicalTrials.gov/show/NCT02853474 |
Recruiting |
Centre Oscar Lambret |
2021-10-31 |
| NCT02842047 |
The Mediating Effects of Decentering on Self-Management of Stress and End of Life Planning |
https://ClinicalTrials.gov/show/NCT02842047 |
Completed |
Case Comprehensive Cancer Center |
2018-03-09 |
| NCT02797197 |
Feasibility of Systematic Handgrip Strength (HGS) Testing and Short-term Changes in Muscle Strength in Digestive Cancer Patients Treated by Chemotherapy |
https://ClinicalTrials.gov/show/NCT02797197 |
Completed |
CHU de Reims |
2017-02-15 |
| NCT02795988 |
A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer |
https://ClinicalTrials.gov/show/NCT02795988 |
Recruiting |
Imugene Limited |
2020-12-31 |
| NCT02785887 |
Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients |
https://ClinicalTrials.gov/show/NCT02785887 |
Completed |
Azienda USL 4 Prato |
2018-09-25 |
| NCT02785783 |
Endoringsâ„¢ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp Detection |
https://ClinicalTrials.gov/show/NCT02785783 |
Completed |
Portsmouth Hospitals NHS Trust |
2018-08-07 |
| NCT02784652 |
Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT02784652 |
Completed |
Severance Hospital |
2017-02-28 |
| NCT02760199 |
89Zr-AMG211 PET Imaging Study |
https://ClinicalTrials.gov/show/NCT02760199 |
Completed |
University Medical Center Groningen |
2017-05-03 |
| NCT02744651 |
EUS-Endodrill vs. EUS-FNA for Diagnosis of Submucosal Tumors in the Upper GI Tract |
https://ClinicalTrials.gov/show/NCT02744651 |
Recruiting |
Region Skane |
2020-09-30 |
| NCT02742935 |
A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects |
https://ClinicalTrials.gov/show/NCT02742935 |
Active, not recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2019-05-06 |
| NCT02713269 |
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord |
https://ClinicalTrials.gov/show/NCT02713269 |
Recruiting |
M.D. Anderson Cancer Center |
2022-07-01 |
| NCT02677129 |
Physical Function and Activities of Daily Living in Cancer Patients During Chemotherapy |
https://ClinicalTrials.gov/show/NCT02677129 |
Completed |
Goethe University |
2016-09-30 |
| NCT02595320 |
Capecitabine in Metastatic Breast and GI Cancers |
https://ClinicalTrials.gov/show/NCT02595320 |
Recruiting |
University of Kansas Medical Center |
2020-12-31 |
| NCT02585362 |
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program |
https://ClinicalTrials.gov/show/NCT02585362 |
Completed |
Kantonsspital Winterthur KSW |
2018-10-31 |
| NCT02584244 |
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT02584244 |
Recruiting |
Lumicell, Inc. |
2020-12-31 |
| NCT02573974 |
Skeletal Muscle Energy Metabolism in Undernourished Patients With Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02573974 |
Completed |
University Hospital, Tours |
2018-12-04 |
| NCT02038114 |
The Impact of a Patient Education Intervention for Ambulatory Oncology Patients |
https://ClinicalTrials.gov/show/NCT02038114 |
Completed |
Sunnybrook Health Sciences Centre |
2014-06-30 |
| NCT02631590 |
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma |
https://ClinicalTrials.gov/show/NCT02631590 |
Active, not recruiting |
H. Lee Moffitt Cancer Center and Research Institute |
2019-11-23 |
| NCT03403465 |
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT03403465 |
Recruiting |
Duke University |
2021-02-28 |
| NCT02507414 |
Mesenteric Traction Syndrome During Upper Gastrointestinal Surgery |
https://ClinicalTrials.gov/show/NCT02507414 |
Completed |
Rigshospitalet, Denmark |
2016-09-30 |
| NCT02486198 |
Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02486198 |
Completed |
Tianjin Medical University Cancer Institute and Hospital |
2018-01-11 |
| NCT02485561 |
Evaluating Strategies to Present Colon Cancer Screening Information |
https://ClinicalTrials.gov/show/NCT02485561 |
Completed |
Washington University School of Medicine |
2017-01-31 |
| NCT02450656 |
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer |
https://ClinicalTrials.gov/show/NCT02450656 |
Recruiting |
The Netherlands Cancer Institute |
2019-05-31 |
| NCT02444572 |
Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® |
https://ClinicalTrials.gov/show/NCT02444572 |
Recruiting |
Les Laboratoires des Médicaments Stériles |
2020-12-31 |
| NCT02381561 |
Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy |
https://ClinicalTrials.gov/show/NCT02381561 |
Active, not recruiting |
National Cancer Institute (NCI) |
2018-11-08 |
| NCT02356471 |
Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT02356471 |
Completed |
Wake Forest University Health Sciences |
2016-10-31 |
| NCT02335619 |
Early Integrated Supportive Care Study for Gastrointestinal Cancer Patients |
https://ClinicalTrials.gov/show/NCT02335619 |
Completed |
British Columbia Cancer Agency |
2018-12-31 |
| NCT02333188 |
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02333188 |
Completed |
University of Chicago |
2017-12-31 |
| NCT02319018 |
Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT02319018 |
Completed |
National Cancer Institute (NCI) |
2018-09-29 |
| NCT02293954 |
Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer |
https://ClinicalTrials.gov/show/NCT02293954 |
Active, not recruiting |
City of Hope Medical Center |
2020-06-30 |
| NCT02275403 |
Standard Care Alone or With Acupuncture for CIPN in Breast Cancer and Multiple Myeloma |
https://ClinicalTrials.gov/show/NCT02275403 |
Completed |
The Christie NHS Foundation Trust |
2018-12-17 |
| NCT02259725 |
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT02259725 |
Active, not recruiting |
University of Southern California |
2020-08-16 |
| NCT03385577 |
Yoga for Psychological Distress in Gynecologic, Gastrointestinal, or Thoracic Cancer |
https://ClinicalTrials.gov/show/NCT03385577 |
Recruiting |
University of Florida |
2020-05-31 |
| NCT02222259 |
A Feasibility Trial of Geriatric Assessment and Management for Older Cancer Patients |
https://ClinicalTrials.gov/show/NCT02222259 |
Completed |
University of Toronto |
2016-08-31 |
| NCT02216799 |
Glargine Insulin vs.Continuous Regular Insulin in Diabetic Surgical Patients Receiving Parenteral Nutrition (GLUCOSE-in-PN) |
https://ClinicalTrials.gov/show/NCT02216799 |
Completed |
King Faisal Specialist Hospital & Research Center |
2015-08-31 |
| NCT02192333 |
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors |
https://ClinicalTrials.gov/show/NCT02192333 |
Active, not recruiting |
Fred Hutchinson Cancer Research Center |
2017-10-07 |
| NCT02174549 |
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer |
https://ClinicalTrials.gov/show/NCT02174549 |
Active, not recruiting |
Teclison Ltd. |
2020-08-31 |
| NCT02148159 |
Acupuncture for Unintentional Weight Loss and Anorexia With GI Cancer |
https://ClinicalTrials.gov/show/NCT02148159 |
Completed |
University of Florida |
2016-05-31 |
| NCT02140593 |
The Laparotomy Study |
https://ClinicalTrials.gov/show/NCT02140593 |
Completed |
Herlev Hospital |
2016-05-31 |
| NCT02130427 |
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy |
https://ClinicalTrials.gov/show/NCT02130427 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2019-10-31 |
| NCT02092298 |
Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer |
https://ClinicalTrials.gov/show/NCT02092298 |
Completed |
M.D. Anderson Cancer Center |
2020-05-12 |
| NCT01291407 |
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer |
https://ClinicalTrials.gov/show/NCT01291407 |
Completed |
Chinese Academy of Medical Sciences |
2013-08-31 |
| NCT02056015 |
A Phase I Study of MLN6907 in Patients With Metastatic Colorectal |
https://ClinicalTrials.gov/show/NCT02056015 |
Completed |
Takeda |
2015-09-30 |
| NCT02045368 |
Study of Insulin-like Growth Factor (IGF)-Methotrexate Conjugate in the Treatment of Advanced Tumors Expressing IGF-1R |
https://ClinicalTrials.gov/show/NCT02045368 |
Completed |
IGF Oncology, LLC |
2016-09-30 |
| NCT01996306 |
A Phase III Study of 2nd-line XELIRI ± Bevacizumab vs. FOLFIRI ± Bevacizumab in mCRC |
https://ClinicalTrials.gov/show/NCT01996306 |
Completed |
Epidemiological and Clinical Research Information Network |
2017-11-20 |
| NCT01995084 |
In Vivo Assessment of Hypoxia in Gastro-intestinal Cancer Using 18F-HX4-PET: an Optimization and Reproducibility Study |
https://ClinicalTrials.gov/show/NCT01995084 |
Completed |
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
2014-06-30 |
| NCT01982994 |
Intervention to Motivate Standing &Walking in Gastrointestinal Cancer Surgical Patients |
https://ClinicalTrials.gov/show/NCT01982994 |
Completed |
Milton S. Hershey Medical Center |
2015-07-31 |
| NCT01976494 |
The Efficacy and Safety of Accufuser Omnibus® (Elastomeric Infusion Pump); Comparative Clinical Trial |
https://ClinicalTrials.gov/show/NCT01976494 |
Completed |
Yonsei University |
2014-07-31 |
| NCT01964430 |
Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the “Apact” Study) |
https://ClinicalTrials.gov/show/NCT01964430 |
Active, not recruiting |
Celgene |
2018-12-31 |
| NCT01946854 |
Crossover Trial of Systemic Chemotherapy in Patients With Metastatic Well-Differentiated Mucinous Appendiceal Adenocarcinomas With Pseudomyxoma Peritonei |
https://ClinicalTrials.gov/show/NCT01946854 |
Recruiting |
M.D. Anderson Cancer Center |
2021-07-31 |
| NCT01927965 |
Study of Minnelideâ„¢ in Patients With Advanced GI Tumors |
https://ClinicalTrials.gov/show/NCT01927965 |
Completed |
Minneamrita Therapeutics LLC |
2016-10-31 |
| NCT01916447 |
A Phase I Study of TAS-102 in Patients With Advanced Gastrointestinal Tumors. |
https://ClinicalTrials.gov/show/NCT01916447 |
Completed |
Taiho Oncology, Inc. |
2017-09-30 |
| NCT01912131 |
Person-Centered Oncology Care and Choices (P-COCC): Piloting and Initial Randomized Testing of a Combined Values Narrative Interview and Video Education Advance Care Planning Program in Gastrointestinal Oncology Patients |
https://ClinicalTrials.gov/show/NCT01912131 |
Completed |
Memorial Sloan Kettering Cancer Center |
2020-01-31 |
| NCT01845337 |
Study to Compare Cardiovascular Side Effects of Teysuno Versus Capecitabine |
https://ClinicalTrials.gov/show/NCT01845337 |
Active, not recruiting |
University of Edinburgh |
2021-07-30 |
| NCT01841736 |
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors |
https://ClinicalTrials.gov/show/NCT01841736 |
Active, not recruiting |
National Cancer Institute (NCI) |
2019-03-05 |
| NCT01833637 |
Electronic Patient Reported Symptom Assessment |
https://ClinicalTrials.gov/show/NCT01833637 |
Completed |
Northwestern University |
2015-06-30 |
| NCT01832116 |
89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients |
https://ClinicalTrials.gov/show/NCT01832116 |
Completed |
University Medical Center Groningen |
2014-05-31 |
| NCT01790035 |
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT01790035 |
Active, not recruiting |
Washington University School of Medicine |
2017-01-12 |
| NCT01730586 |
Abraxane in CIMP-High Colorectal and Small Bowel Adenocarcinomas |
https://ClinicalTrials.gov/show/NCT01730586 |
Completed |
M.D. Anderson Cancer Center |
2016-08-31 |
| NCT01700062 |
Medium Calorie Parenteral Nutrition on Patients With Gastrointestinal Cancer Undergoing Surgery |
https://ClinicalTrials.gov/show/NCT01700062 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2008-11-30 |
| NCT01658813 |
5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer |
https://ClinicalTrials.gov/show/NCT01658813 |
Completed |
Western Regional Medical Center |
2014-07-31 |
| NCT01640665 |
Pilot Study of Sorafenib and Bi-weekly Capecitabine in Patients With Advanced Breast and Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT01640665 |
Completed |
Yale University |
2014-08-31 |
| NCT01639911 |
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors |
https://ClinicalTrials.gov/show/NCT01639911 |
Completed |
University of Illinois at Chicago |
2016-07-28 |
| NCT01625351 |
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas |
https://ClinicalTrials.gov/show/NCT01625351 |
Active, not recruiting |
St. Jude Children’s Research Hospital |
2020-09-18 |
| NCT01567488 |
Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET |
https://ClinicalTrials.gov/show/NCT01567488 |
Completed |
Grupo Espanol de Tumores Neuroendocrinos |
2014-09-01 |
| NCT02024607 |
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02024607 |
Active, not recruiting |
Boston Biomedical, Inc |
2020-06-30 |
| NCT01552291 |
The Impact of Preoperative Oral Glutamine Intake on the Immunocompetence and Outcomes of Malnourished Patients Undergoing Major Abdominal Surgery Due to Malignancies |
https://ClinicalTrials.gov/show/NCT01552291 |
Completed |
University Hospital Inselspital, Berne |
2018-02-10 |
| NCT01540968 |
Nutrition and Physical Exercise Study |
https://ClinicalTrials.gov/show/NCT01540968 |
Completed |
Kantonsspital Winterthur KSW |
2015-03-31 |
| NCT01476592 |
A Biological Study of Resveratrol’s Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT01476592 |
Completed |
University of Wisconsin, Madison |
2013-10-31 |
| NCT01449864 |
Proton Radiotherapy for Upper Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT01449864 |
Completed |
Abramson Cancer Center of the University of Pennsylvania |
2015-12-31 |
| NCT03866525 |
OH2 Oncolytic Viral Therapy in Solid Tumors |
https://ClinicalTrials.gov/show/NCT03866525 |
Recruiting |
Wuhan Binhui Biotechnology Co., Ltd. |
2020-12-31 |
| NCT01434069 |
Phase I Trial of Combination of FOLFIRI and SOM 230 |
https://ClinicalTrials.gov/show/NCT01434069 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2015-12-31 |
| NCT01423799 |
Immunonutrition and Quality of Life of Cancer Patients Undergoing Oncological Treatment |
https://ClinicalTrials.gov/show/NCT01423799 |
Completed |
Nestlé |
2015-10-31 |
| NCT01422993 |
Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced Neuropathy |
https://ClinicalTrials.gov/show/NCT01422993 |
Completed |
H. Lee Moffitt Cancer Center and Research Institute |
2016-04-30 |
| NCT01375699 |
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers |
https://ClinicalTrials.gov/show/NCT01375699 |
Completed |
Virginia Commonwealth University |
2017-08-04 |
| NCT04393584 |
FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT04393584 |
Recruiting |
Blokhin’s Russian Cancer Research Center |
2024-01-01 |
| NCT04298489 |
Drug Sensitivity Screening for Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT04298489 |
Recruiting |
Beijing Cancer Hospital |
2022-04-30 |
| NCT04273061 |
Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity |
https://ClinicalTrials.gov/show/NCT04273061 |
Recruiting |
British Columbia Cancer Agency |
2024-10-31 |
| NCT04207463 |
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT04207463 |
Recruiting |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
2020-12-31 |
| NCT04201730 |
Study on the Efficacy and Safety of Enhanced Recovery After Surgery （ERAS）in Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT04201730 |
Recruiting |
Huashan Hospital |
2020-12-31 |
| NCT04197310 |
Cabozantinib and Nivolumab for Carcinoid Tumors |
https://ClinicalTrials.gov/show/NCT04197310 |
Recruiting |
Dana-Farber Cancer Institute |
2021-12-26 |
| NCT04196465 |
Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT04196465 |
Recruiting |
Asan Medical Center |
2026-09-09 |
| NCT04171141 |
Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors. |
https://ClinicalTrials.gov/show/NCT04171141 |
Recruiting |
Pfizer |
2023-06-14 |
| NCT04145297 |
Ulixertinib (BVD-523) and Hydroxychloroquine in Patients w Advanced MAPK-Mutated Gastrointestinal Adenocarcinomas |
https://ClinicalTrials.gov/show/NCT04145297 |
Recruiting |
University of Utah |
2023-01-30 |
| NCT04131426 |
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia |
https://ClinicalTrials.gov/show/NCT04131426 |
Recruiting |
University of Rochester |
2022-04-01 |
| NCT04084249 |
Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer - Intervention Trial 2 |
https://ClinicalTrials.gov/show/NCT04084249 |
Recruiting |
University of Aarhus |
2022-12-01 |
| NCT04080843 |
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients |
https://ClinicalTrials.gov/show/NCT04080843 |
Recruiting |
Zhejiang University |
2020-08-31 |
| NCT04077372 |
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers |
https://ClinicalTrials.gov/show/NCT04077372 |
Recruiting |
Stanford University |
2020-09-30 |
| NCT04071431 |
A Questionnaire for Endoscopic Prediction Improvement of Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT04071431 |
Recruiting |
Shandong University |
2021-04-30 |
| NCT04032353 |
Medical Consortium for Screening Upper Gastrointestinal Cancers With Magnetically Controlled Capsule Gastroscopy |
https://ClinicalTrials.gov/show/NCT04032353 |
Recruiting |
Shandong University |
2019-12-31 |
| NCT04010227 |
Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers |
https://ClinicalTrials.gov/show/NCT04010227 |
Recruiting |
Indiana University |
2021-05-31 |
| NCT03997617 |
Personalized Functional Profiling in Metastatic Gastrointestinal Cancer or Recurrent Glioblastoma Patients in Luxembourg. |
https://ClinicalTrials.gov/show/NCT03997617 |
Recruiting |
Luxembourg Institute of Health |
2020-12-01 |
| NCT03978078 |
A Clinicobiological Database in Metastatic Digestive Cancers |
https://ClinicalTrials.gov/show/NCT03978078 |
Recruiting |
Institut du Cancer de Montpellier - Val d’Aurelle |
2021-04-30 |
| NCT03958747 |
Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy |
https://ClinicalTrials.gov/show/NCT03958747 |
Recruiting |
Wake Forest University Health Sciences |
2021-08-31 |
| NCT03915171 |
Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer |
https://ClinicalTrials.gov/show/NCT03915171 |
Recruiting |
China Medical University, China |
2019-12-01 |
| NCT03858855 |
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment |
https://ClinicalTrials.gov/show/NCT03858855 |
Completed |
Ohio State University Comprehensive Cancer Center |
2020-04-13 |
| NCT03850912 |
Symptom Management Implementation of Patient Reported Outcomes in Oncology |
https://ClinicalTrials.gov/show/NCT03850912 |
Recruiting |
Dana-Farber Cancer Institute |
2023-05-31 |
| NCT03812796 |
Epigenetic Modulation of the immunE Response in GastrointEstinal Cancers (EMERGE) |
https://ClinicalTrials.gov/show/NCT03812796 |
Recruiting |
Royal Marsden NHS Foundation Trust |
2021-11-30 |
| NCT03807518 |
Pre- and Post-Operative Exercise Program in Upper Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT03807518 |
Recruiting |
Royal College of Surgeons, Ireland |
2020-07-31 |
| NCT03800693 |
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT03800693 |
Recruiting |
Emory University |
2021-03-31 |
| NCT03767660 |
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation |
https://ClinicalTrials.gov/show/NCT03767660 |
Recruiting |
Peking Union Medical College Hospital |
2022-01-01 |
| NCT03745326 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients |
https://ClinicalTrials.gov/show/NCT03745326 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
2027-12-01 |
| NCT03724071 |
Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. |
https://ClinicalTrials.gov/show/NCT03724071 |
Recruiting |
Transgene |
2020-12-31 |
| NCT03723447 |
Intraoperative TAP Block With Bupivacaine/Dexamethasone Against Liposomal Bupivacaine (Exparel®) |
https://ClinicalTrials.gov/show/NCT03723447 |
Active, not recruiting |
Cedars-Sinai Medical Center |
2019-12-31 |
| NCT03717298 |
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT03717298 |
Recruiting |
Catalysis SL |
2020-10-30 |
| NCT03704727 |
The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy |
https://ClinicalTrials.gov/show/NCT03704727 |
Completed |
University of Copenhagen |
2019-02-01 |
| NCT03699332 |
Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin |
https://ClinicalTrials.gov/show/NCT03699332 |
Recruiting |
Radboud University |
2021-03-31 |
| NCT03665714 |
Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT03665714 |
Recruiting |
Nestlé |
2019-08-31 |
| NCT03611309 |
Perioperative Palliative Care Surrounding Cancer Surgery for Patients & Their Family Members |
https://ClinicalTrials.gov/show/NCT03611309 |
Recruiting |
Stanford University |
2021-02-28 |
| NCT03602677 |
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage |
https://ClinicalTrials.gov/show/NCT03602677 |
Recruiting |
Oulu University Hospital |
2020-09-01 |
| NCT03597581 |
A Study of RGX-202-01 With or Without FOLFIRI in Patients With Advanced Gastrointestinal Malignancies |
https://ClinicalTrials.gov/show/NCT03597581 |
Recruiting |
Rgenix, Inc. |
2020-07-31 |
| NCT03576872 |
The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer Patients |
https://ClinicalTrials.gov/show/NCT03576872 |
Completed |
Dana-Farber Cancer Institute |
2019-09-30 |
| NCT03559543 |
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT03559543 |
Recruiting |
Catalysis SL |
2020-11-30 |
| NCT03549494 |
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction |
https://ClinicalTrials.gov/show/NCT03549494 |
Recruiting |
Catalysis SL |
2020-11-01 |
| NCT03535727 |
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer |
https://ClinicalTrials.gov/show/NCT03535727 |
Recruiting |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2021-06-30 |
| NCT03531320 |
Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase |
https://ClinicalTrials.gov/show/NCT03531320 |
Recruiting |
InnoPharmax Inc. |
2019-10-31 |
| NCT03528863 |
Web-based Mindfulness Meditation in Reducing Distress in Participants With Metastatic Gastrointestinal Cancer and Their Caregivers |
https://ClinicalTrials.gov/show/NCT03528863 |
Active, not recruiting |
University of California, San Francisco |
2019-02-28 |
| NCT03515941 |
Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers |
https://ClinicalTrials.gov/show/NCT03515941 |
Recruiting |
Baylor College of Medicine |
2022-10-08 |
| NCT03515356 |
Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy |
https://ClinicalTrials.gov/show/NCT03515356 |
Completed |
University of Michigan Rogel Cancer Center |
2019-06-24 |
| NCT03507998 |
Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT03507998 |
Recruiting |
Curegenix Inc. |
2020-04-01 |
| NCT03502317 |
Prehabilitation to Improve Cancer Surgery Outcomes |
https://ClinicalTrials.gov/show/NCT03502317 |
Recruiting |
Mount Sinai Hospital, Canada |
2020-08-31 |
| NCT03449030 |
A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) |
https://ClinicalTrials.gov/show/NCT03449030 |
Completed |
Takeda |
2020-02-27 |
| NCT03445260 |
PeRioperative Optimization With Nutritional Supplements for Patients Undergoing GastRointEStinal Surgery for Cancer |
https://ClinicalTrials.gov/show/NCT03445260 |
Recruiting |
Hamilton Health Sciences Corporation |
2020-04-01 |
| NCT03411915 |
A Study of XmAb®18087 in Subjects With NET and GIST |
https://ClinicalTrials.gov/show/NCT03411915 |
Recruiting |
Xencor, Inc. |
2021-03-31 |
| NCT01218841 |
Pure Fish Oil Parenteral Lipid Emulsion in Patients With Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT01218841 |
Completed |
University of Sao Paulo |
2008-11-30 |
| NCT01204476 |
Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma |
https://ClinicalTrials.gov/show/NCT01204476 |
Completed |
National Cancer Institute (NCI) |
2014-07-31 |
| NCT01202409 |
CAPOX in KRAS Wild-Type Advanced Adenocarcinoma of the Small Bowel or Ampulla of Vater |
https://ClinicalTrials.gov/show/NCT01202409 |
Completed |
M.D. Anderson Cancer Center |
2018-07-03 |
| NCT01200316 |
Rocking Motion: Physiologic Effect on the Surgical Stress Response |
https://ClinicalTrials.gov/show/NCT01200316 |
Completed |
M.D. Anderson Cancer Center |
2017-11-20 |
| NCT01200121 |
Bevacizumab as a Palliative Treatment for Patients With Symptomatic Malignant Ascites Due to Advanced-stage Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT01200121 |
Completed |
AIO-Studien-gGmbH |
2014-08-31 |
| NCT01155258 |
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT01155258 |
Completed |
University of Southern California |
2013-01-31 |
| NCT01129310 |
First Line Study of Irinotecan, Capecitabine and Oxaliplatin in Metastatic Gastric or Gastroesophageal Cancer. |
https://ClinicalTrials.gov/show/NCT01129310 |
Completed |
AHS Cancer Control Alberta |
2018-05-18 |
| NCT01058655 |
RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT01058655 |
Completed |
Dana-Farber Cancer Institute |
2013-09-30 |
| NCT01046864 |
Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI) |
https://ClinicalTrials.gov/show/NCT01046864 |
Completed |
Bristol-Myers Squibb |
2014-06-30 |
| NCT01037049 |
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks |
https://ClinicalTrials.gov/show/NCT01037049 |
Active, not recruiting |
Royal Marsden NHS Foundation Trust |
2014-12-08 |
| NCT01016639 |
Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer |
https://ClinicalTrials.gov/show/NCT01016639 |
Completed |
Lund University Hospital |
2007-07-31 |
| NCT01010126 |
Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer |
https://ClinicalTrials.gov/show/NCT01010126 |
Completed |
National Cancer Institute (NCI) |
2017-03-13 |
| NCT00990535 |
High Dose Somatostatin Analogues in Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00990535 |
Completed |
Federico II University |
2007-12-31 |
| NCT00855452 |
Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors |
https://ClinicalTrials.gov/show/NCT00855452 |
Completed |
Hadassah Medical Organization |
2014-05-31 |
| NCT00849979 |
Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy |
https://ClinicalTrials.gov/show/NCT00849979 |
Completed |
M.D. Anderson Cancer Center |
2010-01-31 |
| NCT02349958 |
Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy |
https://ClinicalTrials.gov/show/NCT02349958 |
Recruiting |
Bay Area Gynecology Oncology |
2022-01-31 |
| NCT00826410 |
Prospective Study on the Value of Subcutaneous Drains in Gastrointestinal Surgery |
https://ClinicalTrials.gov/show/NCT00826410 |
Completed |
University Hospital Freiburg |
2004-12-31 |
| NCT03245788 |
Effectiveness of Lay Navigators in Meeting Cancer Patients’ Non-Clinical Needs: A Pilot Study |
https://ClinicalTrials.gov/show/NCT03245788 |
Completed |
Stanford University |
2018-07-31 |
| NCT02664974 |
Home Enteral Nutrition in Malnourished Patients With Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT02664974 |
Completed |
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano |
2011-02-28 |
| NCT02221700 |
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies |
https://ClinicalTrials.gov/show/NCT02221700 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-04-30 |
| NCT03294252 |
Oxaliplatin in PIPAC for Nonresectable Peritoneal Metastases of Digestive Cancers |
https://ClinicalTrials.gov/show/NCT03294252 |
Recruiting |
Institut Cancerologie de l’Ouest |
2019-09-12 |
| NCT03037385 |
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT03037385 |
Recruiting |
Blueprint Medicines Corporation |
2021-12-31 |
| NCT02837679 |
Oncogeriatric Intervention and Follow-up at Home |
https://ClinicalTrials.gov/show/NCT02837679 |
Active, not recruiting |
University of Aarhus |
2019-09-30 |
| NCT02575898 |
Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort Study |
https://ClinicalTrials.gov/show/NCT02575898 |
Completed |
Dartmouth-Hitchcock Medical Center |
2018-07-12 |
| NCT01693445 |
S-1, Oxaliplatin, and Irinotecan for Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT01693445 |
Completed |
Hallym University Medical Center |
2014-02-28 |
| NCT04447443 |
Impact of Dietary Fiber as Prebiotics on Chemotherapy-related Diarrhea in Patients With Gastrointestinal Tumors |
https://ClinicalTrials.gov/show/NCT04447443 |
Recruiting |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2021-06-30 |
| NCT04426669 |
A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering |
https://ClinicalTrials.gov/show/NCT04426669 |
Recruiting |
Intima Bioscience, Inc. |
2022-10-31 |
| NCT03858712 |
EHR-embedded OCDT in Breast or GI Cancer |
https://ClinicalTrials.gov/show/NCT03858712 |
Recruiting |
Dana-Farber Cancer Institute |
2021-03-31 |
| NCT00793871 |
Safety And Efficacy Study Of Sunitinib Malate In Chinese Patients With Imatinib Resistant Or Intolerant Malignant Gastrointestinal Stromal Tumor |
https://ClinicalTrials.gov/show/NCT00793871 |
Completed |
Pfizer |
2014-04-30 |
| NCT00788957 |
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC) |
https://ClinicalTrials.gov/show/NCT00788957 |
Completed |
Amgen |
2012-02-29 |
| NCT00752570 |
A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma |
https://ClinicalTrials.gov/show/NCT00752570 |
Completed |
Amgen |
2010-09-30 |
| NCT00725712 |
Study of GSK1363089 in Metastatic Gastric Cancer |
https://ClinicalTrials.gov/show/NCT00725712 |
Completed |
GlaxoSmithKline |
2009-11-01 |
| NCT00680901 |
LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib |
https://ClinicalTrials.gov/show/NCT00680901 |
Active, not recruiting |
Novartis |
2012-09-24 |
| NCT00660153 |
Study of Tivozanib (AV-951) Plus FOLFOX6 in Subjects With Advanced Colorectal Cancer and Other Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT00660153 |
Completed |
AVEO Pharmaceuticals, Inc. |
2012-06-30 |
| NCT00655655 |
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors |
https://ClinicalTrials.gov/show/NCT00655655 |
Completed |
Mayo Clinic |
2009-09-15 |
| NCT00654160 |
Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00654160 |
Completed |
Mayo Clinic |
2010-11-30 |
| NCT00602082 |
Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00602082 |
Completed |
National Cancer Institute (NCI) |
2009-12-31 |
| NCT00585637 |
Vitamin D for Chemoprevention |
https://ClinicalTrials.gov/show/NCT00585637 |
Completed |
Dana-Farber Cancer Institute |
2010-10-31 |
| NCT00583674 |
Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma |
https://ClinicalTrials.gov/show/NCT00583674 |
Completed |
Amgen |
2010-03-31 |
| NCT00570635 |
A Phase 2 Study of XL820 in Adults With Advanced GIST Resistant to Imatinib and/or Sunitinib |
https://ClinicalTrials.gov/show/NCT00570635 |
Completed |
Exelixis |
2009-05-31 |
| NCT00537121 |
Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00537121 |
Completed |
Roswell Park Cancer Institute |
2012-10-31 |
| NCT00526669 |
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib |
https://ClinicalTrials.gov/show/NCT00526669 |
Completed |
GlaxoSmithKline |
2011-04-30 |
| NCT00513357 |
Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients |
https://ClinicalTrials.gov/show/NCT00513357 |
Completed |
M.D. Anderson Cancer Center |
2012-12-31 |
| NCT00486954 |
Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer |
https://ClinicalTrials.gov/show/NCT00486954 |
Completed |
GlaxoSmithKline |
2012-01-31 |
| NCT00465725 |
A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors |
https://ClinicalTrials.gov/show/NCT00465725 |
Completed |
Poniard Pharmaceuticals |
2009-07-31 |
| NCT00454363 |
Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer |
https://ClinicalTrials.gov/show/NCT00454363 |
Completed |
National Cancer Institute (NCI) |
2014-03-31 |
| NCT00436657 |
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer |
https://ClinicalTrials.gov/show/NCT00436657 |
Completed |
M.D. Anderson Cancer Center |
2011-04-30 |
| NCT00436410 |
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer |
https://ClinicalTrials.gov/show/NCT00436410 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00427349 |
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00427349 |
Completed |
Eastern Cooperative Oncology Group |
2014-10-31 |
| NCT00422409 |
Endoscopic Stenting of Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00422409 |
Completed |
Oslo University Hospital |
2009-04-30 |
| NCT00416767 |
Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery |
https://ClinicalTrials.gov/show/NCT00416767 |
Completed |
Federation Francophone de Cancerologie Digestive |
2006-01-31 |
| NCT00397384 |
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer |
https://ClinicalTrials.gov/show/NCT00397384 |
Completed |
National Cancer Institute (NCI) |
2013-06-30 |
| NCT00392366 |
Laser Interstitial Thermal Therapy Under “Real Time” MRI Guidance for “Minimal Invasive” Treatment of Liver Metastasis |
https://ClinicalTrials.gov/show/NCT00392366 |
Completed |
BioTex, Inc. |
NA |
| NCT00390182 |
Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC) |
https://ClinicalTrials.gov/show/NCT00390182 |
Completed |
University of Maryland, Baltimore |
2011-05-31 |
| NCT00356889 |
Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors |
https://ClinicalTrials.gov/show/NCT00356889 |
Completed |
National Cancer Institute (NCI) |
2008-10-31 |
| NCT00354887 |
Capecitabine and Oxaliplatin in Adenocarcinoma of the Small Bowel and Ampulla of Vater |
https://ClinicalTrials.gov/show/NCT00354887 |
Completed |
M.D. Anderson Cancer Center |
2009-11-30 |
| NCT00353015 |
Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract |
https://ClinicalTrials.gov/show/NCT00353015 |
Completed |
M.D. Anderson Cancer Center |
2007-12-31 |
| NCT00289445 |
Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment) |
https://ClinicalTrials.gov/show/NCT00289445 |
Completed |
University Hospital Tuebingen |
2006-03-31 |
| NCT00247338 |
The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients |
https://ClinicalTrials.gov/show/NCT00247338 |
Completed |
Sino-Swed Pharmaceutical Corporation |
2006-04-30 |
| NCT00220168 |
Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours |
https://ClinicalTrials.gov/show/NCT00220168 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00220064 |
A Phase II Trial Evaluating Irinotecan Plus 5FU/LV in Patients With Relapsed/Refractory Upper GI Tumours |
https://ClinicalTrials.gov/show/NCT00220064 |
Completed |
Royal Marsden NHS Foundation Trust |
NA |
| NCT00196885 |
Effect of an Antioxidant on Cancer-Cachectic Patients Undergoing Exercise Training |
https://ClinicalTrials.gov/show/NCT00196885 |
Completed |
German Cancer Research Center |
NA |
| NCT00190801 |
Phase 2 Study on Use of a Combination of Pemetrexed in Patients With Advanced Gastric Carcinoma |
https://ClinicalTrials.gov/show/NCT00190801 |
Completed |
Eli Lilly and Company |
NA |
| NCT00183846 |
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers |
https://ClinicalTrials.gov/show/NCT00183846 |
Completed |
University of Southern California |
2007-10-31 |
| NCT00131911 |
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00131911 |
Completed |
National Cancer Institute (NCI) |
2010-10-31 |
| NCT00120939 |
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer |
https://ClinicalTrials.gov/show/NCT00120939 |
Completed |
Pharmacyclics LLC. |
NA |
| NCT00094965 |
Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function |
https://ClinicalTrials.gov/show/NCT00094965 |
Completed |
Sanofi |
2007-08-31 |
| NCT00093782 |
Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma |
https://ClinicalTrials.gov/show/NCT00093782 |
Completed |
National Cancer Institute (NCI) |
2011-04-30 |
| NCT00089960 |
Study of AMG 706 in Subjects With Advanced Gastrointestinal Stromal Tumors (GISTs) |
https://ClinicalTrials.gov/show/NCT00089960 |
Completed |
Amgen |
2006-06-30 |
| NCT00086762 |
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors |
https://ClinicalTrials.gov/show/NCT00086762 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2024-12-31 |
| NCT00003427 |
Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer |
https://ClinicalTrials.gov/show/NCT00003427 |
Completed |
Memorial Sloan Kettering Cancer Center |
2002-04-30 |
| NCT00019474 |
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer |
https://ClinicalTrials.gov/show/NCT00019474 |
Completed |
Montefiore Medical Center |
2000-08-31 |
| NCT00006368 |
Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer |
https://ClinicalTrials.gov/show/NCT00006368 |
Completed |
Novartis |
2003-11-30 |
| NCT00017199 |
PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00017199 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00075439 |
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00075439 |
Completed |
National Cancer Institute (NCI) |
2007-05-31 |
| NCT00004074 |
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu |
https://ClinicalTrials.gov/show/NCT00004074 |
Completed |
National Cancer Institute (NCI) |
2009-02-28 |
| NCT00004911 |
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction |
https://ClinicalTrials.gov/show/NCT00004911 |
Completed |
Northwestern University |
2003-02-28 |
| NCT00004910 |
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction |
https://ClinicalTrials.gov/show/NCT00004910 |
Completed |
Northwestern University |
2003-02-28 |
| NCT00055809 |
Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors |
https://ClinicalTrials.gov/show/NCT00055809 |
Completed |
National Cancer Institute (NCI) |
2007-06-30 |
| NCT00052962 |
Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal Carcinomatosis |
https://ClinicalTrials.gov/show/NCT00052962 |
Completed |
National Institutes of Health Clinical Center (CC) |
2008-09-30 |
| NCT00049023 |
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors |
https://ClinicalTrials.gov/show/NCT00049023 |
Completed |
University of Iowa |
2011-08-31 |
| NCT00031681 |
7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) |
https://ClinicalTrials.gov/show/NCT00031681 |
Completed |
National Cancer Institute (NCI) |
2011-01-31 |
| NCT00027638 |
Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors |
https://ClinicalTrials.gov/show/NCT00027638 |
Completed |
Memorial Sloan Kettering Cancer Center |
2003-12-31 |
| NCT00002470 |
Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors |
https://ClinicalTrials.gov/show/NCT00002470 |
Completed |
National Cancer Institute (NCI) |
NA |
| NCT00001431 |
A Phase I Trial of Gemcitabine and Radiation in Locally Advanced Unresectable Cancer of the Pancreas |
https://ClinicalTrials.gov/show/NCT00001431 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00041808 |
Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver |
https://ClinicalTrials.gov/show/NCT00041808 |
Completed |
FeRx |
NA |